This metabolic reprogramming upregulates hepatic recruitment and activation of CXCR6+ natural killer T (NKT) cells via bile acid receptor signaling, ultimately preventing HCC (66–68) (Figure 3). Here, CXCR6 is linked to hepatocellular carcinoma.